Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 25, 2004Journal of VirologyOpen Access

Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNatalie SutkowskiGCGang ChenGCGermán Calderón

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sutkowski et al. (2004) studied this question.

synapsesocial.com/papers/6a8139bb9fceb4fbd5e3de68https://doi.org/10.1128/jvi.78.14.7852-7860.2004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity1992 · 207 citations
  2. 2Polyadenylation at correct sites in genome RNA is not required for retrovirus replication or genome encapsidation1989 · 38 citations
  3. 3Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.1990 · 103 citations
  4. 4Virus-encoded superantigens1996 · 55 citations
  5. 5Differences Between Laboratory Strains of Epstein-Barr Virus Based on Immortalization, Abortive Infection, and Interference1974 · 273 citations